Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05897528 · ClinicalTrials.gov registry record
Insulin Regulation and Severity of Severe Acute Respiratory Syndrome COVID-19 Infection
A clinical trial, sponsored by Arrowhead Regional Medical Center.
- Completed
- Registry status
- 589
- Enrollment target
NCT05897528: Completed study, sponsored by Arrowhead Regional Medical Center.
NCT05897528 is a clinical trial that has completed, run by Arrowhead Regional Medical Center. The registered enrollment target is 589 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05897528 has completed, sponsored by Arrowhead Regional Medical Center.
- COMPLETED
- Registry status
- 589 participants
- Enrollment target
Study Summary
The Coronavirus Disease of 2019 (COVID-19) pandemic has caused an international healthcare crisis and produced a large healthcare burden. Diabetes mellitus is a common disease that can be controlled via pharmacologic agents; however, many patients have poor glycemic control, leading to disease-related complications. Diabetes mellitus has been reported in the literature to be associated with increasing morbidity and mortality in COVID-19 patients, and some hypothesize that this is due to insulin dysregulation propagating a pro-inflammatory state. The investigators aim to contribute to the growing body of literature that assesses the associations between glucose homeostasis and COVID-19 disease severity and mortality.
Primary Outcome
The time spent hospitalized in days.
Interventions
- OTHER No Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 589 participants |
| Start Date | 2021-10-14 |
| Est. Completion | 2022-12-30 |
What the finished NCT05897528 record still lists
NCT05897528 is an observational study that tracks outcomes without assigning an intervention. The registered 589 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No Intervention is the first listed.
NCT05897528 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05897528 about?
NCT05897528 is a clinical study titled "Insulin Regulation and Severity of Severe Acute Respiratory Syndrome COVID-19 Infection". The Coronavirus Disease of 2019 (COVID-19) pandemic has caused an international healthcare crisis and produced a large healthcare burden. Diabetes mellitus is a common disease that can be controlled via pharmacologic agents; however, many patients have poor glycemic control, leading to disease-relat...
What is the current status of trial NCT05897528?
This trial is currently completed. The enrollment target is 589 participants. The study started on 2021-10-14. Estimated completion is 2022-12-30.
What interventions are being tested in trial NCT05897528?
The interventions under investigation include: No Intervention (OTHER).
Who is sponsoring clinical trial NCT05897528?
This trial is sponsored by Arrowhead Regional Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01365169 · 590 participants · NA
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
- NCT03774758 · 590 participants
Biomarkers for Risk Stratification in Lung Cancer
- NCT04747626 · 590 participants · NA
B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair
- NCT05722938 · 590 participants · Phase 3
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI